Back to search

Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells

Data up to Jan 2025

Published2002
Citations87
References41

Total Citations Per Year

Abstract

References (41)

Antibodies, a laboratory manual

1989 • 12,929 citations

Angiogenesis in cancer, vascular, rheumatoid and other disease

1995 • 7,717 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Antibodies: A laboratory manual

1989 • 4,532 citations

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

1987 • 3,809 citations

The Transforming Growth Factor-beta Family

1990 • 3,028 citations

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

1986 • 2,878 citations

TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders

2000 • 2,354 citations

Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma

1982 • 1,225 citations

Anti-Angiogenesis

1972 • 1,167 citations

TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1999 • 969 citations

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells

2001 • 854 citations

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system

1991 • 661 citations

TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

1998 • 630 citations

Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.

1990 • 617 citations

Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix.

1988 • 571 citations

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.

1990 • 470 citations

Tumor suppressor activity of the TGF-β pathway in human cancers

1996 • 412 citations

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

1990 • 398 citations

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

1993 • 356 citations

Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.

1989 • 346 citations

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells

1995 • 340 citations

Defective repression of c- myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program

2001 • 320 citations

Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression.

1997 • 284 citations

Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration.

1988 • 237 citations

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

1991 • 216 citations

Heterogeneity of human colon carcinoma

1984 • 165 citations

Metastasis from human breast cancer cell lines

1996 • 159 citations

Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β Superfamily

2001 • 148 citations

Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

1992 • 147 citations

A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.

1999 • 116 citations

TGF-β and cancer

1999 • 115 citations

Expression of Scatter Factor in Human Bladder Carcinoma

1995 • 107 citations

Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent

2001 • 86 citations

Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern.

1996 • 85 citations

Transforming growth factor β and cancer

1995 • 73 citations

Expression of Transforming Growth Factor β Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells

1997 • 69 citations

Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose.

1988 • 69 citations

Expression of Transforming Growth Factor β (TGFβ) Type III Receptor Restores Autocrine TGFβ1 Activity in Human Breast Cancer MCF-7 Cells

1997 • 58 citations

Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent

2001 • 55 citations

Potentiation of Metastatic Capacity by Transforming Growth Factor‐β1 Gene Transfection

1993 • 30 citations

Cited By (0)

Loading...
Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in… (2002) – Oncogene | Metascience Observatory Explorer